Abbott Informatics Europe BV
STARLIMS, an Abbott Company, helps laboratories optimize data management, accessibility, integrity and long-term value by providing your lab with the powerful, efficient tools and support you need to achieve your goals.
Our unified web-based platform includes our award-winning Laboratory Information Management Systems (LIMS), Electronic Laboratory Notebook (ELN) and a Scientific Data Management System (SDMS).
We have almost 25 years of experience working with hundreds of laboratories in the public health, environmental, petrochemical, forensic, pharmaceutical, clinical and diagnostic sectors.
Most importantly, every department in our company is aligned toward one goal: meeting and surpassing customer expectations of our products and services.
- Focus : Manufacturer
- Industry : IT
News about Abbott
08-Jul-2021 | business & finance
Francisco Partners to Acquire STARLIMS
Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, announced that it has signed a definitive ...
24-Mar-2010 | business & finance
Abbott Completes Acquisition of STARLIMS Technologies
Abbott announced that it has completed its $123 million acquisition of STARLIMS Technologies Ltd. The acquisition provides Abbott with products and ...
14-Oct-2008 | manufacturing
Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen
Abbott announced the opening of new development laboratories and a pilot plant facility that will research technologies and test large-scale production of ...
06-Dec-2006 | business & finance
Abbott's Acquisition of Kos Pharmaceuticals, Inc. Clears Antitrust Review
Abbott announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements ...
24-Apr-2006 | manufacturing
Abbott to Invest S$450 Million (US$280 Million) in Largest Nutritional Plant in Singapore
State-of-the-Art Manufacturing Facility to Support Rapidly Growing Demand for Abbott Nutritional Products in Asia
25-Jan-2006 | research and development
New Real-Time PCR Test for Chlamydia and Gonorrhea Receives CE Mark Certification
Abbott announced that a highly sensitive new test for the simultaneous detection of the sexually transmitted pathogens Chlamydia trachomatis (CT) and ...
27-Dec-2005 | research and development
Eisai Submits New Drug Application for Rheumatoid Arthritis Drug Adalimumab (D2E7)
Eisai Co., Ltd and Abbott Japan Co., Ltd submitted a new drug application (NDA) to the Minister of Health Labour and Welfare (MHLW) for the manufacturing ...